Literature DB >> 29620996

Advances in Adjuvant Therapy for Colon Cancer: P value or Practical Value.

Alan P Venook1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29620996     DOI： 10.1200/JCO.2018.77.8423

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Long non-coding RNA TUG1 promotes the proliferation of colorectal cancer cells through regulating Wnt/β-catenin pathway.

Authors:  Chun Hong Xiao; Hai Zhong Yu; Chun Yan Guo; Zhi Mei Wu; Hong Yan Cao; Wei Bing Li; Jian Fen Yuan
Journal:  Oncol Lett       Date:  2018-08-03       Impact factor: 2.967

Review 2.  Treatment of Rectal Cancer in Older Adults.

Authors:  Ayesha R Sheikh; Hassan Yameen; Kevan Hartshorn
Journal:  Curr Oncol Rep       Date:  2018-11-20       Impact factor: 5.075

Review 3.  The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective.

Authors:  Giacomo Bregni; Sara Elena Rebuzzi; Alberto Sobrero
Journal:  Curr Treat Options Oncol       Date:  2019-01-26

4.  Identification of critical genes to predict recurrence and death in colon cancer: integrating gene expression and bioinformatics analysis.

Authors:  Xuan Long; Zhigang Deng; Guoqiang Li; Ziwei Wang
Journal:  Cancer Cell Int       Date:  2018-09-17       Impact factor: 5.722
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.